Akira Miyajima Selected Research

poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate)

4/2015

Therapeutic effect of intravesical administration of paclitaxel solubilized with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) in an orthotopic bladder cancer model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akira Miyajima Research Topics

Disease

89	Neoplasms (Cancer) 03/2022 - 08/2002
52	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 08/2005
33	Carcinoma (Carcinomatosis) 01/2022 - 09/2006
32	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 05/2006
23	Renal Cell Carcinoma (Grawitz Tumor) 03/2022 - 08/2002
15	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2002
8	Non-Muscle Invasive Bladder Neoplasms 06/2017 - 04/2011
7	Pneumoperitoneum 01/2022 - 12/2013
5	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 11/2020 - 05/2015
5	Pheochromocytoma 01/2018 - 03/2009
5	Hydronephrosis 01/2015 - 11/2007
4	Overactive Urinary Bladder (Overactive Bladder) 11/2020 - 05/2015
4	Hemorrhage 10/2015 - 12/2005
4	Carcinogenesis 07/2015 - 07/2004
4	Abdominal Obesity 04/2015 - 12/2012
3	Inguinal Hernia (Direct Inguinal Hernia) 01/2021 - 04/2010
3	Erectile Dysfunction 10/2020 - 05/2011
3	Lymphocele 04/2013 - 01/2008
3	Hematuria 08/2012 - 01/2002
3	Fibrosis (Cirrhosis) 10/2009 - 04/2003
3	Ureteral Obstruction 10/2009 - 04/2003
2	Obesity 01/2022 - 01/2015
2	Sarcopenia 11/2021 - 01/2021
2	Carcinoma in Situ 01/2021 - 03/2011
2	Hypertension (High Blood Pressure) 01/2021 - 05/2006
2	Wounds and Injuries (Trauma) 08/2020 - 01/2020
2	Delayed Graft Function 01/2020 - 11/2013
2	Shock 09/2017 - 10/2006
2	Fever (Fevers) 01/2017 - 06/2009
2	Inflammation (Inflammations) 12/2016 - 11/2013

Drug/Important Bio-Agent (IBA)

13	Prostate-Specific Antigen (Semenogelase)IBA 11/2019 - 07/2007
10	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 12/2008
10	AndrogensIBA 12/2016 - 01/2007
10	Angiotensin IIIBA 03/2012 - 08/2002
8	Docetaxel (Taxotere)FDA Link 10/2017 - 01/2010
6	C-Reactive ProteinIBA 03/2022 - 01/2008
6	Indicators and Reagents (Reagents)IBA 01/2021 - 08/2012
6	NF-kappa B (NF-kB)IBA 04/2015 - 04/2003
5	Hemoglobins (Hemoglobin)IBA 03/2022 - 01/2007
5	Dutasteride (Avodart)FDA Link 05/2018 - 01/2014
5	Biomarkers (Surrogate Marker)IBA 02/2018 - 11/2013
5	Paclitaxel (Taxol)FDA LinkGeneric 04/2015 - 02/2007
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2010 - 08/2002
5	Angiotensin II Type 1 Receptor BlockersIBA 05/2009 - 05/2006
5	candesartanIBA 03/2009 - 08/2002
4	CreatinineIBA 03/2022 - 01/2008
4	SteroidsIBA 01/2021 - 01/2013
4	Biological ProductsIBA 10/2020 - 12/2010
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2007
4	Alkaline PhosphataseIBA 11/2016 - 08/2006
4	Gemcitabine FDA Link 04/2015 - 12/2008
4	dehydroxymethylepoxyquinomicinIBA 11/2013 - 04/2003
4	Hormones (Hormone)IBA 02/2010 - 08/2005
3	CytokinesIBA 01/2022 - 04/2010
3	Analgesics (Analgesic Drugs)IBA 01/2020 - 09/2011
3	dactolisibIBA 09/2015 - 01/2014
3	Small Interfering RNA (siRNA)IBA 07/2015 - 12/2010
3	Therapeutic UsesIBA 04/2015 - 03/2009
3	Fluorouracil (Carac)FDA LinkGeneric 09/2014 - 09/2012
3	EnzymesIBA 09/2014 - 09/2012
3	Type 1 Angiotensin ReceptorIBA 03/2012 - 11/2010
3	Angiogenesis InhibitorsIBA 05/2009 - 05/2006
3	Interleukin-6 (Interleukin 6)IBA 01/2008 - 08/2005
2	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2014
2	NivolumabIBA 09/2020 - 09/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2017 - 11/2010
2	PlatinumIBA 11/2016 - 04/2015
2	Matrix Metalloproteinases (MMPs)IBA 07/2015 - 02/2010
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 07/2015 - 02/2010
2	SmokeIBA 07/2015 - 02/2010
2	Mechanistic Target of Rapamycin Complex 1IBA 07/2015 - 01/2014
2	Antineoplastic Agents (Antineoplastics)IBA 04/2015 - 03/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2015 - 12/2008
2	Methotrexate (Mexate)FDA LinkGeneric 04/2015 - 12/2008
2	Vinblastine (Vinblastine Sulfate)FDA Link 04/2015 - 12/2008
2	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 09/2014 - 09/2012

Therapy/Procedure

33	Therapeutics 01/2022 - 08/2002
19	Nephroureterectomy 11/2021 - 01/2002
16	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 01/2008
16	Castration 03/2020 - 06/2011
15	Nephrectomy 01/2022 - 05/2003
13	Drug Therapy (Chemotherapy) 01/2021 - 12/2008
9	Adrenalectomy 08/2020 - 11/2010
9	Operative Time 01/2016 - 05/2011
6	Intravesical Administration 01/2021 - 04/2011
6	Cystectomy 01/2020 - 11/2006
5	Radiotherapy 01/2022 - 12/2009
4	Transurethral Resection of Bladder 01/2021 - 06/2009
4	Lymph Node Excision (Lymph Node Dissection) 04/2013 - 01/2008
3	Length of Stay 05/2021 - 09/2011
3	Brachytherapy 03/2016 - 12/2009
3	Catheters 07/2015 - 01/2008
2	Operative Surgical Procedures 01/2022 - 01/2015
2	Transrectal High-Intensity Focused Ultrasound 01/2021 - 01/2018
2	Renal Dialysis (Hemodialysis) 01/2021 - 08/2012
2	Aftercare (After-Treatment) 10/2020 - 09/2014
2	Neoadjuvant Therapy 01/2020 - 07/2011
2	Blood Transfusion (Blood Transfusions) 01/2020 - 12/2005
2	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 09/2017 - 10/2006
2	Immunotherapy 09/2014 - 04/2011